BioArctic AB. (8/22/24). "Press Release: Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain". Stockholm. |
2024-08-22 |
Bico Group AB. (7/10/24). "Press Release: Andréas Joersjö Appointed as General Counsel for Bico Group AB". |
2024-07-10 |
Genovis AB. (7/4/24). "Press Release: Genovis Completes a Strategic Investment in Sequrna, a Developer of Next-generation RNase Inhibitors". Ghent. |
2024-07-04 |
Moleculent AB. (6/11/24). "Press Release: Moleculent Launches with $26 Million Series A Financing to Advance the Spatial Mapping of Cell-Cell Communication". Stockholm. |
2024-06-11 |
Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company". |
2024-05-28 |
ArgusEye AB. (5/13/24). "Press Release: ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing". Stockholm. |
2024-05-13 |
Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. |
2024-04-17 |
Protembis GmbH. (3/26/24). "Press Release: Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors". Aachen. |
2024-03-26 |
Bico Group AB. (3/15/24). "Press Release: Founders Leave after Eight Years". |
2024-03-15 |
Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund. |
2024-03-14 |
Gedea Biotech AB. (2/29/24). "Press Release: The Swedish Femtech Company Gedea Biotech Selected for Prestigious Grant Funding from the European Innovation Council, EIC". |
2024-02-29 |
InflaRx N.V.. (2/22/24). "Press Release: InflaRx Appoints Jan Medina as Head of Investor Relations". Jena. |
2024-02-22 |
FyoniBio GmbH. (2/7/24). "Press Release: FyoniBio Collaborates with BioLamina and Alder Therapeutics". Berlin. |
2024-02-07 |
AAX Biotech AB. (11/28/23). "Press Release: AAX Biotech Forms Strategic Collaboration with Oblique Therapeutics for Therapeutic Antibody Development". |
2023-11-28 |
Owkin. (11/21/23). "Press Release: Owkin Expands Reach of AI Diagnostic for Colorectal Cancer through Integration with Sectra". |
2023-11-21 |
Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". |
2023-11-21 |
InDex Pharmaceuticals Holding AB. (11/21/23). "Press Release: InDex Pharmaceuticals Discontinues Cobitolimod Phase III Program". |
2023-11-21 |
Bico Group AB. (11/13/23). "Press Release: BICO Has Divested Ginolis through a Management Buy-out to Ginolis’ Current CEO Kauko Väinämö. The Purchase Price amounted to €1". |
2023-11-13 |
Bico Group AB. (11/13/23). "Press Release: Maria Forss Assumes Office as BICO’s CEO and President on November 20, 2023". |
2023-11-13 |
Thermo Fisher Scientific Inc.. (10/17/23). "Press Release: Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics". Waltham, MA & Uppsala. |
2023-10-17 |
CombiGene AB. (10/14/23). "Press Release: Spark Therapeutics Terminates Collaboration Agreement for the Epilepsy Project CG01 with CombiGene". Stockholm. |
2023-10-14 |
Bico Group AB. (10/11/23). "Press Release: Cellink and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence". San Diego, CA. |
2023-10-11 |
AAX Biotech AB. (9/28/23). "Press Release: AAX Biotech Welcomes New CEO to Drive Advancements in Next-generation Antibody Therapeutics". |
2023-09-28 |
Lauxera Capital Partners. (9/12/23). "Press Release: Lauxera Capital Partners Invests €17 Million in Swedish Regenerative Medicine Leader BioLamina AB". Paris & San Francisco, CA. |
2023-09-12 |
Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)". |
2023-08-21 |
Bico Group AB. (8/21/23). "Press Release: Bico Announces Goodwill Impairment Predominantly Due to Increased WACC, and Write-downs of Assets". |
2023-08-21 |
BioLamina AB. (8/16/23). "Press Release: BioLamina Announces Appointment of New Management Team Members". |
2023-08-16 |
NorthX Biologics. (7/3/23). "Press Release: NorthX Biologics, a Leading Nordic Development and Manufacturing Organisation Announces Acquisition of a Biologics Manufacturing Unit from Valneva". Matfors. |
2023-07-03 |
EBD Group. (6/27/23). "Press Release: BIO-Europe 2024 Is Going to Stockholm". Munich. |
2023-06-27 |
VarmX B.V.. (5/25/23). "Press Release: VarmX Raises €30 Million Series B2 Financing for IND Approval and Preparations for Pivotal Trial". Leiden. |
2023-05-25 |
Biocartis Group N.V.. (5/9/23). "Press Release: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test". Mechelen. |
2023-05-09 |
Neogap Therapeutics AB. (5/4/23). "Press Release: Neogap and Cellerys Enter Collaboration Related to Phase II Study of a New Therapy for Multiple Sclerosis". |
2023-05-04 |
Capitainer AB. (4/4/23). "Press Release: Capitainer Launches Fully Automated Sample Handler". Stockholm. |
2023-04-04 |
Alligator Bioscience AB. (3/22/23). "Press Release: Alligator Intends to Carry Out a 91 Percent Secured Rights Issue of Units of Approximately SEK 199 Million [Not for US, AU, et al.]". |
2023-03-22 |
Teitur Trophics ApS. (3/14/23). "Press Release: Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases". Aarhus. |
2023-03-14 |
EQL Pharma AB. (3/13/23). "Press Release: EQL Pharma Recruits Carl Lindgren as Chief Business Development Officer". |
2023-03-13 |
Oncopeptides AB. (3/8/23). "Press Release: Oncopeptides CSO Investigated for Violation of the Market Abuse Act". |
2023-03-08 |
Biotage AB. (2/15/23). "Press Release: Biotage Strengthens Its Position as a Global Chromatography Leader with the Transformative Acquisition of Astrea Bioseparations". Uppsala. |
2023-02-15 |
Novalis Biotech. (2/6/23). "Press Release: Novalis Biotech Invests in Rarity Bioscience’s Ultra Sensitive Genomics Technology". Uppsala. |
2023-02-06 |
va-Q-tec AG. (1/30/23). "Press Release: Management and Supervisory Boards of va-Q-tec AG Recommend Acceptance of EQT Private Equity’s Voluntary Public Takeover Offer". Würzburg. |
2023-01-30 |
Capitainer AB. (1/30/23). "Press Release: Capitainer Announces Collaboration with AstraZeneca". Stockholm. |
2023-01-30 |
Alzinova AB. (1/24/23). "Press Release: Alzinova Recruits Business Development Director". |
2023-01-24 |
AI Medical Technology. (1/24/23). "Press Release: AI Medical Technology Nets SEK10.8 Million to Accelerate Dermalyser AI-driven Diagnostic Support Tool for Skin Cancer". Stockholm. |
2023-01-24 |
Sigrid Therapeutics AB. (1/16/23). "Press Release: Sigrid Therapeutics Raises further SEK10.6 Million in Oversubscribed Rights Issue for Accelerated SiPore Commercialization". Stockholm. |
2023-01-16 |
Oncopeptides AB. (1/11/23). "Press Release: Oncopeptides Appoints Holger Lembrer as Chief Financial Officer". Stockholm. |
2023-01-11 |
TATAA Biocenter AB. (1/11/23). "Press Release: TATAA Biocenter Partners with Universal Sequencing Technology Corporation to Offer “Linked Long Read” Sequencing Services". |
2023-01-11 |
Oncopeptides AB. (1/4/23). "Press Release: Monica Shaw Appointed CEO of Oncopeptides – Jakob Lindberg Assumes Position as Chief Scientific Officer". Stockholm. |
2023-01-04 |
Bico Group AB. (1/2/23). "Press Release: Bico Group Appoints New CFO". |
2023-01-02 |
European Invesmtent Bank (EIB). (12/23/22). "Press Release: Sweden – EIB Lends €20 Million to Biotech Company for Development of Biopharmaceuticals to Treat Cancer and Inflammatory Diseases". |
2022-12-23 |
Affibody Medical AB. (12/23/22). "Press Release: Affibody Signs €20 Million Loan Agreement with the EIB to Finance the Development of Next Generation’s Biopharmaceuticals against Cancer and Inflammatory Diseases". Solna. |
2022-12-23 |
ADC Therapeutics S.A.. (12/21/22). "Press Release: ADC Therapeutics and Sobi Announce European Commission Approval of Zynlonta (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma". Lausanne. |
2022-12-21 |
Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen. |
2022-12-08 |
Oncopeptides AB. (12/7/22). "Press Release: Oncopeptides Provides Update on Pepaxto US Marketing Authorization". Stockholm. |
2022-12-07 |
Rarity Bioscience AB. (11/29/22). "Press Release: Rarity Bioscience Raises €2.5M in Seed Funding to Improve Cancer Care". Uppsala. |
2022-11-29 |
FyoniBio GmbH. (10/20/22). "Press Release: FyoniBio and Strike Pharma Sign a Master Service Agreement Covering Cell Line Development for a Novel Bi-specific Therapeutic mAb". Berlin & Stockholm. |
2022-10-20 |
Adelis Equity Partners. (8/22/22). "Press Release: Adelis Equity Partners Raises Fund Continuation Vehicle for SSI Diagnostica Group, Enabling Transformational Acquisition". |
2022-08-22 |
Evitria AG. (8/8/22). "Press Release: Genovis AB Enters Service Agreement with Evitria AG for Fast LC-MS Analysis of Recombinant Antibodies". |
2022-08-08 |
Active Biotech AB. (8/4/22). "Press Release: Active Biotech Announces a Rights Issue of approximately SEK 55 Million [Not for release in US, AU, CA, JP, et al.]". |
2022-08-04 |
Scienion GmbH. (7/28/22). "Press Release: Scienion Announces Expansion in the UK with the Opening of New R&D and Manufacturing Facilities". Lakeside North Harbour, Portsmouth. |
2022-07-28 |
Lidds AB. (7/15/22). "Press Release: Lidds AB (publ) Announces the Appointment of Anders Månsson as CEO". Uppsala. |
2022-07-15 |
BioInvent International AB. (7/12/22). "Press Release: BioInvent Has Successfully Carried Out a Directed Share Issue of approximately SEK 300 Million (approximately USD 28.3 Million) [ Not for US, AU, et al. ]". Lund. |
2022-07-12 |
Navinci Diagnostics AB. (7/12/22). "Press Release: Navinci Diagnostics AB Announces Closing of SEK 90M Series A Financing, Led by Segulah Medical Acceleration with Support from Existing Shareholders". |
2022-07-12 |
ADC Therapeutics S.A.. (7/8/22). "Press Release: ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize Zynlonta (loncastuximab tesirine-lpyl) in Europe and Select International Territories". Lausanne. |
2022-07-08 |
EQT AB. (6/22/22). "Press Release: EQT Private Equity to Acquire SPT Labtech, a Fast-growing Laboratory Automation Player Focused on Low-volume Liquid Handling Technology for GBP 650 Million from Battery Ventures". Stockholm. |
2022-06-22 |
Elypta AB. (6/20/22). "Press Release: Elypta Raises $21 Million Series A to Develop Metabolism-based Multi-cancer Early Detection Test". Stockholm. |
2022-06-20 |
Roslin Cell Therapies Ltd. (RoslinCT). (6/15/22). "Press Release: RoslinCT Appoints Lee Warren as Chief Financial Officer". Edinburgh. |
2022-06-15 |
Ariceum Therapeutics GmbH. (6/8/22). "Press Release: Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers". Berlin. |
2022-06-08 |
UK Government (Office for Life Sciences). (5/27/22). "Press Release: UK Commits to Life Sciences Cooperation with Sweden". |
2022-05-27 |
Cinclus Pharma Holding AB. (5/20/22). "Press Release: Cinclus Pharma Has Carried Out a Successful Private Placement of approximately SEK 240m". Stockholm. |
2022-05-20 |
Artax Biopharma, Inc.. (5/11/22). "Press Release: Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases". Cambridge, MA. |
2022-05-11 |
Bico Group AB. (5/6/22). "Press Release: Bico Acquires Allegro 3D, Adding New Light-based 3D Bioprinting Technology – Complementing the Existing Offering of Application Tailored products". |
2022-05-06 |
Bico Group AB. (4/29/22). "Press Release: New Interim CFO at BICO". |
2022-04-29 |
Bico Group AB. (4/26/22). "Press Release: BICO’s CFO Gusten Danielsson Leaves His Assignment". |
2022-04-26 |
XNK Therapeutics AB. (3/29/22). "Press Release: XNK Therapeutics Raises SEK 132 Million to Accelerate Growth". |
2022-03-29 |
Abera Bioscience AB. (3/29/22). "Press Release: Abera Bioscience Signs Agreement with NorthX Biologics for GMP Manufacturing". |
2022-03-29 |
Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. |
2022-03-10 |
EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". |
2022-03-01 |
Strike Pharma AB. (2/22/22). "Press Release: Strike Pharma Completes 45 MSEK Financing Round". Uppsala. |
2022-02-22 |
Recipharm AB. (2/18/22). "Press Release: Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced Therapy Medicinal Products (ATMPs), to Expand Its Biologics Offering in the US". |
2022-02-18 |
Recipharm AB. (2/18/22). "Press Release: Recipharm Expands Its Advanced Therapy Medicinal Products (ATMPs) Offering into Virotherapies with the Acquisition of Vibalogics". |
2022-02-18 |
Life Sciences Partners (LSP). (2/11/22). "Press Release: LSP Closes EUR 1 Billion Flagship Fund LSP 7 to Invest in Life Sciences Companies". Amsterdam. |
2022-02-11 |
Recipharm AB. (2/1/22). "Press Release: Recipharm Acquires GenIbet to Bolster Biologics Offering". |
2022-02-01 |
CombiGene AB. (1/25/22). "Press Release: CombiGene Signs Agreement to Evaluate the Leading Gene Therapy Candidate within the Lipodystrophy Project CGT2". |
2022-01-25 |
Amniotics AB. (1/20/22). "Press Release: Amniotics Secures Funding of SEK 4,8 Million from Vinnova to Develop Stem Cell Therapies". |
2022-01-20 |
Sound Bioventures Management AB. (1/4/22). "Press Release: Sound Bioventures Raises € 110 Million for New Biotherapeutics Venture Fund". Malmö & Copenhagen. |
2022-01-04 |
Bico Group AB. (12/16/21). "Press Release: Bico Has Entered into an Agreement to Acquire Biosero, a Leading Software Provider for Automated Workflows and Laboratory Connectivity". |
2021-12-16 |
CombiGene AB. (12/16/21). "Press Release: CombiGene and Spark Therapeutics Plan to Expand the Clinical Development Program to Include the U.S. as Well as Europe". |
2021-12-16 |
Bico Group AB. (12/15/21). "Press Release: Cellink and Nanoscribe Join Forces to Launch the Quantum X bio, the World’s Most Accurate 3D Bioprinter". |
2021-12-15 |
Eir Ventures Partners AB. (12/9/21). "Press Release: Eir Ventures Closes Life Science Venture Fund at EUR122 million". Stockholm & Copenhagen. |
2021-12-09 |
Eir Ventures Partners AB. (12/6/21). "Press Release: Eir Ventures Completes Investment in ArgusEye to Advance Innovative Sensor Technology for Real-time Monitoring of Bioproduction processes". Stockholm. |
2021-12-06 |
Aqilion AB. (12/3/21). "Press Release: Aqilion Strengthens the Company’s Pipeline through the Acquisition of a Phase-1 Ready Anti-inflammatory Program from LEO Pharma". |
2021-12-03 |
Immunovia AB. (11/30/21). "Press Release: Immunovia’s CEO to Step Down during 2022". Lund. |
2021-11-30 |
Qlife Holding AB. (11/29/21). "Press Release: Qlife Recruits Kasper Damgaard Rousøe as New Chief Financial Officer". |
2021-11-29 |
Bico Group AB. (11/17/21). "Press Release: Bico Announces Appointment of Susan Tousi as New Member of the Board of Directors". |
2021-11-17 |
Synklino ApS. (11/15/21). "Press Release: Financing Round in Synklino Heavily Oversubscribed". Copenhagen. |
2021-11-15 |
EQT AB. (11/10/21). "Press Release: EQT Strengthens Position in Healthcare Investments by Joining Forces with LSP". |
2021-11-10 |
Asgard Therapeutics AB. (11/9/21). "Press Release: Asgard Therapeutics Raises EUR 6M in Seed Financing to Exploit Direct in vivo Reprogramming". Lund. |
2021-11-09 |
Immunicum AB. (10/26/21). "Press Release: Immunicum Appoints Lotta Ferm as Chief Financial Officer". |
2021-10-26 |
Medivir AB. (10/25/21). "Press Release: Medivir Appoints Jens Lindberg as Chief Executive Officer". Stockholm. |
2021-10-25 |
Bico Group AB. (10/15/21). "Press Release: Bico Completes the Acquisition of QInstruments". |
2021-10-15 |